Literature DB >> 16359347

The pathophysiology of non-cardiac chest pain.

Daniel Van Handel1, Ronnie Fass.   

Abstract

Various underlying mechanisms have been described in patients with non-cardiac chest pain (NCCP). By far, gastroesophageal reflux disease (GERD) is the most common cause and thus requires initial attention when patients with NCCP are managed. Esophageal dysmotility can be demonstrated in 30% of the NCCP patients, but appears to play a very limited role in symptom generation. A significant number of patients with NCCP lack any evidence of GERD and have been consistently shown to have reduced perception thresholds for pain. Peripheral and/or central sensitization have been suggested to be responsible for visceral hypersensivity in NCCP patients. Further understanding of the underlying mechanisms for pain in patients with NCCP will likely improve our current therapeutic approach.

Entities:  

Mesh:

Year:  2005        PMID: 16359347     DOI: 10.1111/j.1440-1746.2005.04165.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  12 in total

1.  Hypnosis for non-cardiac chest pain.

Authors:  O S Palsson; W E Whitehead
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 2.  The hypersensitive esophagus: pathophysiology, evaluation, and treatment options.

Authors:  Jose M Remes-Troche
Journal:  Curr Gastroenterol Rep       Date:  2010-10

3.  Clinical distinct features of noncardiac chest pain in young patients.

Authors:  Tae Ho Seo; Jeong Hwan Kim; Jung Hyeon Lee; Soon Young Ko; Sung Noh Hong; In-Kyung Sung; Hyung Seok Park; Chan Sub Shim
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

4.  Oesophageal mastocytosis: eosinophilic oesophagitis without eosinophils?

Authors:  Donevan Westerveld; Jian Li; Sarah Glover
Journal:  BMJ Case Rep       Date:  2017-08-28

5.  Origin of and therapeutic approach to cardiac syndrome X: results of the proton pump inhibitor therapy for angina-like lingering pain trial (PITFALL trial).

Authors:  Christoph-G Dietrich; Susanne Laupichler; Sven Stanzel; Ron Winograd; Oliver Al-Taie; Carsten Gartung; Andreas Geier
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

6.  The relevance of accuracy of heartbeat perception in noncardiac and cardiac chest pain.

Authors:  Stefanie Schroeder; Alexander L Gerlach; Stephan Achenbach; Alexandra Martin
Journal:  Int J Behav Med       Date:  2015-04

7.  Low-dose amitriptyline combined with proton pump inhibitor for functional chest pain.

Authors:  Se Woo Park; Hyuk Lee; Hyun Jik Lee; Jun Chul Park; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee; Ji Eun Kim
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

8.  Recent advances in noncardiac chest pain in Korea.

Authors:  Jeong Hwan Kim; Poong-Lyul Rhee
Journal:  Gut Liver       Date:  2012-01-12       Impact factor: 4.519

Review 9.  Prevalence and prognosis of non-specific chest pain among patients hospitalized for suspected acute coronary syndrome - a systematic literature search.

Authors:  Vidar Ruddox; Mariann Mathisen; Jan Erik Otterstad
Journal:  BMC Med       Date:  2012-06-12       Impact factor: 8.775

10.  Esophageal Mast Cell Infiltration in a 32-Year-Old Woman with Noncardiac Chest Pain.

Authors:  Keol Lee; Hee Jin Kwon; In Young Kim; Kwai Han Yoo; Seulkee Lee; Yang Won Min; Poong-Lyul Rhee
Journal:  Gut Liver       Date:  2016-01       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.